CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 46 enrolled
Drug / intervention
sodium hyaluronatedrug
Likely dose
sodium hyaluronate 2 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00918736
NCT00918736Phase 2Completed
CompareCT.gov

Hyaluronans in the Treatment of Ankle Osteoarthritis

Kaohsiung Veterans General Hospital.·interventional·Posted Jun 11, 2009·Updated Jun 17, 2009

In Brief

A Phase 2 clinical trial evaluating sodium hyaluronate for Osteoarthritis. Completed, enrolled 46 participants across 1 site.

Detailed Summary

The aim of this study was to investigate the efficacy and safety of three weekly intraarticular injections of Hyaluronate (HA) in patients with unilateral ankle Osteoarthritis (OA).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesTaiwan
CollaboratorsNational Science and Technology Council, Taiwan

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 11, 2009
Enrollment StartOct 1, 2007
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 17.1 years ago

Interventions

sodium hyaluronatedrug

3 weekly intraarticular injections of 2 ml sodium hyaluronate (Hyalgan) into the ankle joints.